Photo from wikipedia
Treatment continuity remains a clinical challenge. In this review, patients completed a median of just 1.7 treatments—significantly fewer than the median 4.7 treatments patients received in pivotal North American Phase… Click to show full abstract
Treatment continuity remains a clinical challenge. In this review, patients completed a median of just 1.7 treatments—significantly fewer than the median 4.7 treatments patients received in pivotal North American Phase 3 clinical trials,–and many have not yet completed their treatment series. To encourage treatment continuity, the authors have established an office protocol for booking multiple treatments at baseline and emphasizing the need for a minimum of 2 treatments to produce optimal results.
Journal Title: Dermatologic Surgery
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!